Kaplan Fox & Kilsheimer LLP Encourages Smartsheet Inc. (NYSE: SMAR) Investors to Contact the Firm Before October 5, 2026

Kaplan Fox & Kilsheimer filed a proposed class action on behalf of Smartsheet shareholders who sold stock between June 1 and September 23, 2024, alleging the company repurchased shares while aware of a formal acquisition offer from Blackstone and Vista Equity at prices above the market. The complaint alleges Smartsheet should have disclosed the offer or refrained from buybacks; investors have until October 5, 2026 to seek lead-plaintiff status. The litigation creates governance and potential liability risk for Smartsheet, though the claims remain allegations and no damages figure was disclosed.

Analysis

This is primarily a governance overhang rather than a fundamental earnings event. A plaintiff-law-firm solicitation is not evidence of liability, and damages would likely be constrained by the repurchase volume, the price differential, board-process discovery, and any transaction-related indemnification; the probability-weighted impact on Blackstone (BX) is immaterial relative to fee-related earnings and AUM. There is no read-through to BAC or Autoliv (ALV), whose inclusion appears non-economic.

The relevant market mechanism is whether discovery exposes deficiencies in the target's special-committee, disclosure, or capital-allocation process that could create transaction-delay leverage. In the next 1-3 months, headline risk can widen any residual SMAR deal spread and modestly raise perceived execution risk; over 6-18 months, a material ruling could marginally reinforce the preference for rapid disclosure when issuers repurchase shares amid inbound strategic interest. The stronger contrarian view is that the claim is largely backward-looking and offers no actionable edge unless a court denies dismissal or the buyer seeks to reprice, delay, or invoke a closing-condition remedy.

Monitor the lead-plaintiff filing, the eventual complaint, repurchase authorization and actual buyback volumes, and any merger-proxy disclosures on process and indemnification. Thesis falsification for a litigation-risk view is a routine closing or dismissal/settlement with no buyer concession; conversely, a disclosed injunction request, document production revealing a prolonged undisclosed offer process, or a widening deal spread would justify reassessment.

Key Decisions for Investors

• No directional position in BX on this item; treat any litigation-driven weakness as noise unless it coincides with a transaction-delay disclosure or a measurable revision to BX fee-related earnings outlook.
• For merger-arbitrage books with SMAR exposure, retain only normal deal-spread sizing and set an alert for a material spread widening versus comparable cash-deal spreads; do not add solely on the law-firm announcement.
• Avoid using BAC or ALV as thematic expressions: no identifiable revenue, balance-sheet, or operating linkage is supported by the underlying mechanism.
• Revisit after the operative complaint or dismissal ruling: a credible allegation tied to quantified repurchases and transaction-process documents—not a solicitation notice—would be the threshold for modeling legal reserves or closing-risk probabilities.